glp 1 pediatric obesity Weighing up the options: childhood intervention to tackle GLP-1 Receptor Agonists for Obesity

Learn how GLP-1 receptor agonists help patients with type 2 diabetes and obesity manage blood sugar, lose weight, and protect heart health.

Consumers using the meds were more likely to be between 40 and 64 years of age

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

Regulatory pressure, lower prices, and new retail agreements are shifting the balance in the US GLP-1 market.

Real-world comparison of GLP-1 and metformin for PCOS: low one-year adherence, differing costs, side effects, and benefits of combination therapy.